CJC-1295 no-DAC, also known as modified GRF(1-29), is a synthetic GHRH analogue without a drug affinity complex. It is used in literature around GHRH receptor signalling, endocrine marker models, and peptide structure-function comparison.
The no-DAC distinction matters. Without the DAC albumin-binding modification, this material is normally discussed separately from CJC-1295 with DAC and is often compared with Sermorelin, Tesamorelin, and growth-hormone secretagogue peptides such as Ipamorelin.
Customers usually choose CJC-1295 no-DAC when they want a GHRH-pathway reference that is easy to compare against related endocrine signalling peptides. The specification table gives the sequence, mass, salt-form, purity, and handling information for the supplied product.
The references below are starting points for the mechanisms discussed here. The specification table on this page covers identity, formula, molecular mass, physical form, solubility, storage, and lot-level analytical information.
References
Research-use notice: Supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law. Not for human or animal use, consumption, diagnosis, treatment, food, supplement, cosmetic, veterinary, or similar end use.
